Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease Inhibitor
Open Access
- 1 March 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (12) , 8205-8215
- https://doi.org/10.1074/jbc.m510246200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Acquisition of Multi-PI (Protease Inhibitor) Resistance in HIV-1 In Vivo and In VitroCurrent Pharmaceutical Design, 2004
- Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In VitroAntimicrobial Agents and Chemotherapy, 2004
- In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061Journal of Biological Chemistry, 2004
- Evaluation of an early intervention Tier 2 child and adolescent mental health serviceHealth & Social Care in the Community, 2004
- An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003
- Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine ProteaseScience, 2003
- In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide InhibitorJournal of Virology, 2003
- Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcomeProceedings of the National Academy of Sciences, 2002
- Longitudinal Evaluation of the Structure of Replicating and Circulating Hepatitis C Virus Quasispecies in Nonprogressive Chronic Hepatitis C PatientsJournal of Virology, 2001
- Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In VivoJournal of Virology, 2000